Newborn platelets: Lower levels of protease-activated receptors cause hypoaggregability to thrombin

Platelets

Volumn 21, Issue 8, 2010, Pages 641-647

  Schlagenhauf, A ^a   Schweintzger, S ^a   Birner Gruenberger, R ^a   Leschnik, B ^a   Muntean, W ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Newborn platelets; platelet aggregation; protease activated receptors; thrombin receptors; Western blot

Indexed keywords

GLYCOPROTEIN IB ALPHA; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; THROMBIN RECEPTOR;

ADULT; ANALYZER; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEWBORN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; THROMBOCYTE; THROMBOCYTE AGGREGATION; WESTERN BLOTTING;

ADULT; BLOOD COAGULATION TESTS; BLOOD PLATELETS; FETAL BLOOD; HEMOSTASIS; HUMANS; INFANT, NEWBORN; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN ISOFORMS; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; THROMBIN;

EID: 78149422282     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.504869     Document Type: Article

References (33)

1. Cvirn G, Gallistl S, Koestenberger M, Kutschera J, Leschnik B, Muntean W. Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasma. Thromb Res 2002;105:433-439. (Pubitemid 34621261)
2. Cvirn G, Gallistl S, Rehak T, Juergens G, Muntean W. Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma. J Thromb Haemost 2003;1:1785-1790.
3. Cvirn G, Gallistl S, Leschnik B, Muntean W. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 2003;1:263-268.
4. Muntean W, Leschnik B, Baier K, Cvirn G, Gallistl S. In vivo thrombin generation in neonates. J Thromb Haemost 2004;2:2071-2072.
5. Cvirn G, Koestenberger M, Leschnik B, Male C, Kutschera J, Ferstl U, Muntean W, Juergens G, Gallistl S. Protein S modulates the anticoagulant action of recombinant human activated protein C: A comparison between neonates and adults. Br J Pharmacol 2005;146:1082-1086. (Pubitemid 41785320)
6. Fritsch P, Cvirn G, Cimenti C, Baier K, Koestenberger M, Gallistl S, Roschitz B, Leschnik B, Muntean W. Thrombin generation in factor VIII-depleted neonatal plasma: Nearly normal because of physiologically low antithrombin and tissue factor pathway inhibitor. J Thromb Haemost 2006;4:1071-1077.
7. Michelson AD. Platelet function in the newborn. Semin Thromb Hemost 1998;24:507-512.
8. Israels SJ, Daniels M, McMillan EM. Deficient collagen-induced activation in the newborn platelet. Pediatr Res 1990;27:337-343. (Pubitemid 20114006)
9. Mull MM, Hathaway WE. Altered platelet function in newborns. PediatrRes 1970;4:229-237.
10. Rajasekhar D, Kestin AS, Bednarek FJ, Ellis PA, Barnard MR, Michelson AD. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994;72:957-963.
11. Weinstein MJ, Blanchard R, Moake JL, Vosburgh E, Moise K. Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. Br J Haematol 1989;72:68-72. (Pubitemid 19133771)
12. Rehak T, Cvirn G, Gallistl S, Leschnik B, Koestenberger M, Katzer H, Ribitsch V, Muntean W. Increased shear stress-and ristocetin-induced binding of von Willebrand factor to platelets in cord compared with adult plasma. Thromb Haemost 2004;92:682-687. (Pubitemid 39386691)
13. Grosshaupt B, Muntean W, Sedlmayr P. Hyporeactivity of neonatal platelets is not caused by preactivation during birth. Eur J Pediatr 1997;156:944-948. (Pubitemid 28006314)
14. Nicolini U, Guarneri D, Gianotti GA, Campagnoli C, Crosignani PG, Gatti L. Maternal and fetal platelet activation in normal pregnancy. Obstet Gynecol 1994;83:65-69. (Pubitemid 24027383)
15. Irken G, Mutafoglu Uysal K, Olgun N, Undar B, Akkoc N, Ozkan H, Akyol F, Cevik NT. Platelet activation during the early neonatal period. Biol Neonate 1998;73:166-171. (Pubitemid 28069940)
16. Bernhard H, Rosenkranz A, Petritsch M, Koefeler H, Rehak T, Novak M, Muntean W. Phospholipid content, expression and support of thrombin generation of neonatal platelets. Acta Paediatr 2009;98:251-255.
17. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64:1057-1068.
18. Coughlin SR, Vu TK, Hung DT, Wheaton VI. Expression cloning and characterization of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Semin Thromb Hemost 1992;18:161-166.
19. Coughlin SR. How the protease thrombin talks to cells. Proc Natl Acad Sci USA 1999;96:11023-11027.
20. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese Jr RV, Tam C, Coughlin SR. A dual thrombin receptor system for platelet activation. Nature 1998;394:690-694. (Pubitemid 28389797)
21. De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem 1994;269:6478-6484. (Pubitemid 2050751)
22. Mazzucato M, Marco LD, Masotti A, Pradella P, Bahou WF, Ruggeri ZM. Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation. J Biol Chem 1998;273:1880-1887. (Pubitemid 28069229)
23. Hayes KL, Tracy PB. The platelet high affinity binding site for thrombin mimics hirudin, modulates thrombin-induced platelet activation, and is distinct from the glycoprotein Ib-IX-V complex. J Biol Chem 1999;274:972-980. (Pubitemid 129535259)
24. Greco NJ, Tandon NN, Jones GD, Kornhauser R, Jackson B, Yamamoto N, Tanoue K, Jamieson GA. Contributions of glycoprotein Ib and the seven transmembrane domain receptor to increases in platelet cytoplasmic [Ca2+] induced by alpha-thrombin. Biochemistry 1996;35:906-914. (Pubitemid 26034576)
25. Greco NJ, Jones GD, Tandon NN, Kornhauser R, Jackson B, Jamieson GA. Differentiation of the two forms of GPIb functioning as receptors for alpha-thrombin and von Willebrand factor: Ca2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide. Biochemistry 1996;35:915-921. (Pubitemid 26034577)
26. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000;407:258-264.
27. Ramakrishnan V, DeGuzman F, Bao M, Hall SW, Leung LL, Phillips DR. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci USA 2001;98:1823-1828. (Pubitemid 32165582)
28. Ramstroem S, Oberg KV, Akerstroem F, Enstroem C, Lindahl TL. Platelet PAR1 receptor density-correlation to platelet activation response and changes in exposure after platelet activation. Thromb Res 2008;121:681-688.
29. Pietrucha T, Wojciechowski T, Greger J, Jedrzejewska E, Novak S, Chrul S, Golanski J, Watala C. Differentiated reactivity of whole blood neonatal platelets to various agonists. Platelets 2001;12:99-107. (Pubitemid 32284944)
30. Corby DG, O'Barr TP. Decreased alpha-adrenergic receptors in newborn platelets: Cause of abnormal response to epi-nephrine. Dev Pharmacol Ther 1981;2:215-225.
31. Israels SJ, Odaibo FS, Robertson C, McMillan EM, McNicol A. Deficient thromboxane synthesis and response in platelets from premature infants. Pediatr Res 1997;41:218-223. (Pubitemid 27066347)
32. Israels SJ, Cheang T, Roberston C, McMillan-Ward EM, McNicol A. Impaired signal transduction in neonatal platelets. PediatrRes 1999;45:687-691. (Pubitemid 29203602)
33. Sitaru AG, Holzhauer S, Speer CP, Singer D, Obergfell A, Walter U, Grossmann R. Neonatal platelets from cord blood and peripheral blood. Platelets 2005;16:203-210. (Pubitemid 40910909)